So, Larotrectinib is a super specific TRK inhibitor. It goes after TRKA, TRKB, and TRKC. It’s mainly used for adults and kids with tough-to-operate or spread-out NTRK-fusion cancer.
You can get it in capsules (25 mg or 100 mg) or a liquid form (20 mg per milliliter). Adults usually take 100 mg twice a day. For kids, the dose depends on their body size.
They come in bottles with 60 capsules.
